Delivery Order SPE2DB24D1021-SPE2DB25FETDU
Award Date
1/14/25
Potential Completion Date
1/15/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of XIFAXAN 550 mg tablets to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $30,902.72 and an ultimate completion date of July 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,903.45 firm-fixed-price delivery order is for XIFAXAN 550 mg tablets and has a March 2024 completion date. This contract is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that provides a wide range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $6,437.97 firm-fixed-price delivery order from the Defense Logistics Agency (DLA) for the supply of XIFAXAN 550 MG tablets. The contract has an ultimate completion date of January 30, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of XIFAXAN 550 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $79,759.27 and a final completion date of November 6, 2023. The contract is a firm fixed-price Delivery Order, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order with a Firm Fixed Price, is for the supply of XIFAXAN 550 mg tablets and has a ceiling value of $10,048.20. The contract has an ultimate completion date of January 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order against the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The award, valued at $11,837.36, is for the delivery of XIFAXAN 550 MG tablets to support federal healthcare programs. The contract has a period of performance through October 2024 and does not have a set-aside designation, indicating open competition. As a critical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $24,162.73, is a Delivery Order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of XIFAXAN 550 mg tablets to the U.S. Department of Defense's Medical Supply Chain. The single-award, firm-fixed-price, indefinite delivery contract (IDC) has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $10,945.66 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of XIFAXAN 550 MG TABLET 60S. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has an ultimate completion date of June 10, 2024 and a ceiling value of $4,642.33. The contract is for the supply of XIFAXAN 550 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...